John Blamoun MD FCCP
Critical Care Medicine, Interventional Pulmonology, Sleep Medicine
Professor of Medicine Clinical Assistant Dean Central Michigan University Midland campus
Join to View Full Profile
4201 Campus Ridge DriveMidland, MI 48640
Phone+1 989-488-5450
Fax+1 989-488-5455
Dr. Blamoun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Blamoun is a pulmonologist in Midland, MI and is affiliated with multiple hospitals in the area, including McLaren Flint, Aleda E. Lutz Veterans Affairs Medical Center, MidMichigan Medical Center-Clare, MidMichigan Medical Center-Gladwin, and MidMichigan Medical Center-Midland. He received his medical degree from Cairo University School of Medicine and has been in practice 19 years. He specializes in critical care medicine, interventional pulmonology, and pleural disease.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2009
Seton Hall University-Hackensack Meridian School of MedicineFellowship, Pulmonary Disease, 2006 - 2008
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2006
Cairo University School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2024 - Present
MI State Medical License 2009 - 2028
IL State Medical License 2020 - 2026
IA State Medical License 2012 - 2025
NJ State Medical License 2006 - 2009
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia Start of enrollment: 2022 Apr 27
- Add-on Reparixin in Adult Patients With ARDS Start of enrollment: 2022 Dec 06
Publications & Presentations
PubMed
- Development and Validation of the Hospital Medicine Safety Sepsis Initiative Mortality Model.Hallie C Prescott, Megan Heath, Elizabeth S Munroe, John Blamoun, Paul Bozyk
Chest. 2024-11-01 - 2 citationsAbatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.Stephen J Balevic, Daniel K Benjamin Jr, William G Powderly, P Brian Smith, Daniel Gonzalez
JAMA Network Open. 2024-04-01 - 38 citationsAbatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.Jane A O'Halloran, Emily R Ko, Kevin J Anstrom, Eyal Kedar, Matthew W McCarthy
JAMA. 2023-07-25
Press Mentions
Frontline Healthcare Workers See the Toll of Pandemics on Unvaccinated PatientsOctober 1st, 2021- COVID-19 Hospitalizations Rising, Causing Concern for Doctors in MichiganApril 15th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
